Recursion Pharmaceuticals Inc (RXRX)
6.40
+0.08
(+1.27%)
USD |
NASDAQ |
Nov 01, 16:00
6.405
0.00 (0.00%)
After-Hours: 20:00
Recursion Pharmaceuticals Profit Margin (Quarterly): -677.2% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -677.2% |
| March 31, 2024 | -677.3% |
| December 31, 2023 | -875.3% |
| September 30, 2023 | -920.8% |
| June 30, 2023 | -696.5% |
| March 31, 2023 | -538.4% |
| December 31, 2022 | -420.4% |
| September 30, 2022 | -463.1% |
| Date | Value |
|---|---|
| June 30, 2022 | -856.7% |
| March 31, 2022 | -1.06K% |
| December 31, 2021 | -2.60K% |
| September 30, 2021 | -1.90K% |
| June 30, 2021 | -1.74K% |
| March 31, 2021 | -1.23K% |
| December 31, 2020 | -1.01K% |
| September 30, 2020 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-2.77K%
Minimum
Sep 2020
-420.4%
Maximum
Dec 2022
-1.15K%
Average
-898.1%
Median
Profit Margin (Quarterly) Benchmarks
| Eli Lilly and Co | 8.48% |
| Pfizer Inc | 25.22% |
| Revance Therapeutics Inc | -57.31% |
| Twist Bioscience Corp | -105.0% |
| NovaBay Pharmaceuticals Inc | -66.04% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -79.57% |
| Return on Assets | -57.07% |
| Return on Invested Capital | -78.34% |
| Gross Profit Margin (Quarterly) | 36.14% |
| Operating Margin (Quarterly) | -698.0% |
| Return on Net Operating Assets | -167.8% |